Sex-related differences in the association between SAF levels and anti-VEGF IVI treatment number might be related to female hormones such as estradiol and estrogen, which may have a protective effect against neurodegenerative diseases, most likely via activation of the antioxidant defense system [22–24]. The gene discussed is VEGFA; the disease is neurodegenerative disease.